《半日總結》恆指跌141點 藥明生物挫逾8% 海底撈彈高
美10月新增非農職位勝預期,惟亞洲股市早市普遍偏軟,港股亦跟隨下跌。恆指低開126點,早段跌幅曾擴大至236點見24,633點,其後跌幅收窄至32點見24,837點,半日跌141或0.57%,報24,720點;國指跌46點或0.52%,報8,774點;恆生科技指數跌89點或1.43%,報6,187點。大市半日成交總額691.28億元,滬、深港通南下交易半日分別淨流入6.27億及1,050萬元人民幣。
市傳港府力爭下月底前與內地有限度通關,特首指港珠澳橋或有機會成爲首批開放口岸之一。濠賭股上升,銀娛(00027.HK)及澳博(00880.HK)各升5%及5.5%,金沙中國(01928.HK)升7%,永利澳門(01128.HK)及美高梅中國(02282.HK)亦各升3.7%及4.5%。
旅遊平臺股攜程(09961.HK)及同程藝龍(00780.HK)各升5.9%及7%。本地地產股九倉置業(01997.HK)升3.9%,綜合類股太古A(00019.HK)升2.9%。本地股份周生生(00116.HK)、莎莎(00178.HK)及六福(00590.HK)各升2.9%至3.3%。旅行箱生產商新秀麗(01910.HK)炒高13.8%。
航空股國泰(00293.HK)升4.5%,東航(00670.HK)升7%,國航(00753.HK)及南航(01055.HK)各升10.9%及10.5%,北京首都機場(00694.HK)及中國民航信息(00696.HK)各升8.9%及7.1%。
科技股普遍肩軟,騰訊(00700.HK)跌1.3%報461.2元,阿裏巴巴(09988.HK)跌2.3%報156.2元,美團(03690.HK)跌1.8%報271.8元,小米(01810.HK)升0.2%報20.45元,京東(09618.HK)跌1.9%報303.8元,百度(09888.HK)跌2.9%報155.1元,快手(01024.HK)跌2.9%報92.5元。平安好醫生(01833.HK)及易鑫(02858.HK)各跌5.3%及4.7%,微盟(02013.HK)跌3.1%。手機相關股方面,舜宇(02382.HK)跌5.9%,通達(00698.HK)及富智康(02038.HK)各升5.9%及4.4%,比亞迪電子(00285.HK)升2.2%。
醫藥股受壓,騰盛博藥(02137.HK)、三葉草生物(02197.HK)、再鼎醫藥(09688.HK)及康希諾生物(06185.HK)各跌15.3%至25.6%。藥明生物(02269.HK)跌8.3%。
內地餐飲股海底撈(06862.HK)擬關閉300間門店,半日股價升6.9%。同業九毛九(09922.HK)及呷哺呷哺(00520.HK)各升7.4%及4.2%,海底撈供應商頤海(01579.HK)則跌8%。
內房股普遍反彈,碧桂園(02007.HK)及富力(02777.HK)各升2.2%及2.9%,萬科(02202.HK)升6.1%。奧園系續弱,奧園(03883.HK)及奧園健康(03662.HK)各跌4.6%及8.6%。領展(00823.HK)斥逾31億元收購澳洲悉尼三個零售物業50%權益,每基金單位升1.5%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.